
Opinion|Videos|June 11, 2024
Balancing Clinical and Economic Factors in Early Breast Cancer Treatment
The panelists discuss the clinical and economic factors that influence treatment decisions for early breast cancer (eBC), as well as the differences between eBC and metastatic breast cancer (mBC) in terms of adverse event management protocols and strategies for optimizing patient adherence.
Advertisement
Episodes in this series

Video content above is prompted by the following questions:
- What is the current standard of care for early breast cancer?
- What role do academic and community pharmacists have in the treatment plan?
- What are the clinical and economic considerations that go into deciding on a treatment option for eBC?
- What is the difference between eBC and mBC in terms of AE protocols and adherence optimization?
- Can any mBC practices apply to eBC?
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Pharmacy Times
1
Updated 2025-2026 COVID-19 Vaccine Nearly Halved ED Visits, Hospitalizations in CDC-Funded Study
2
Medicare Is Finally Covering GLP-1s for Weight Loss: What the Bridge Program Means for Your Practice
3
FDA Narrows Compounding Rules for GLP-1s: How Pharmacists Should Respond
4
The Biosimilar Conversation Nobody Is Having at the Pharmacy Counter: Why Adoption Is Still Struggling and What We Can Do About It
5





















































































































